Document is current
Any future updates will be listed below
-
Authors
Cruces Olivar, Marcos
Burboa, Allan D.
Gómez, Yolanda M.
- License Information
-
More Information
This article is maintained by: Elsevier
Article Title: Survival of first line biological and targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis in Chile
Journal Title: Reumatología Clínica (English Edition)
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.reumae.2025.501946
Content Type: simple-article
Copyright: © 2025 Sociedad Española de Reumatología (SER), Colegio Mexicano de Reumatología (CMR) and Elsevier España, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
